Add Yahoo as a preferred source to see more of our stories on Google. Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic ...
The efficacy of tolvaptan was demonstrated in two pivotal trials, lasting one year and three years, respectively. Otsuka announced that the Food and Drug Administration (FDA) has approved Jynarque ...
Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has approved JYNARQUE ™ (tolvaptan) as the first drug treatment to slow kidney function decline in ...
Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic Kidney Disease (PKD) Awareness Day, an initiative that aims to increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results